In addition to the fundraise, which will be used to expand the startup’s product development and global reach, Healthy.io was also granted marketing authorization from the FDA for its diagnostic software. The urinalysis uses machine learning to transform a smartphone camera into a clinical-grade medical device, able to aid in the diagnosis of chronic kidney disease.
The startup also announced the addition of Gary Loveman, PhD, to its board of directors. Most recently, Dr. Loveman served as executive vice president of Aetna and president of Healthagen, the company’s consumer health and services business.
“Today, too many patients face barriers to care, leading to missed appointments, undiagnosed conditions, and increased visits to the emergency room or hospital. Healthy.io is establishing itself as a leader in a new world of broader, decentralized access to care without compromising on clinical quality,” Dr. Loveman said in a statement.
More articles on health IT:
How CEOs can play a role in addressing internal IT issues
Obama’s tech chief on how healthcare CIO, CTO job duties should be split
Dana-Farber, Philips data-driven precision oncology platform goes live
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.